Myoferlin Expression and Its Correlation with FIGO Histologic Grading in Early-Stage Endometrioid Carcinoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: For endometrioid carcinoma patients, International Federation of Gynecologists and Obstetricians (FIGO) histologic grading is very important for identifying the appropriate treatment method. However, the interobserver discrepancy with this three-tiered grading system is a serious potential problem. In this study, we used immunohistochemistry to analyze the relationship between FIGO histologic grading score and myoferlin expression. Methods: We studied the endometrioid carcinoma tissues of 60 patients from Gyeongsang National University Hospital between January 2002 and December 2009. Immunohistochemical analysis of myoferlin was performed on tissue microarray blocks from surgical specimens. Results: Myoferlin expression was observed in 58 of 60 patients. Moderate and strong myoferlin expression was observed in low-grade endometrioid carcinoma, while there was a tendency toward loss of myoferlin expression in high-grade endometrioid carcinoma (p < .001). Conclusions: Our study revealed that myoferlin loss is significantly correlated with high FIGO grade of endometrioid carcinoma.
Abstract
Background: For endometrioid carcinoma patients, International Federation of Gynecologists and Obstetricians (FIGO) histologic grading is very important for identifying the appropriate treatment method. However, the interobserver discrepancy with this three-tiered grading system is a serious potential problem. In this study, we used immunohistochemistry to analyze the relationship between FIGO histologic grading score and myoferlin expression. Methods: We studied the endometrioid carcinoma tissues of 60 patients from Gyeongsang National University Hospital between January 2002 and December 2009. Immunohistochemical analysis of myoferlin was performed on tissue microarray blocks from surgical specimens. Results: Myoferlin expression was observed in 58 of 60 patients. Moderate and strong myoferlin expression was observed in low-grade endometrioid carcinoma, while there was a tendency toward loss of myoferlin expression in high-grade endometrioid carcinoma (p < .001). Conclusions: Our study revealed that myoferlin loss is significantly correlated with high FIGO grade of endometrioid carcinoma.
참고문헌 (17)
- Dvalishvili I, "Clinical characteristics of prognostic factors in uterine endometrioid adenocarcinoma of various grade", Georgian Med News, (132), pp.24~27 (2006)
- Zaki MA, "Histological grade predicts for recurrence in patients with uterine endometrioid carcinoma without myometrial involvement", Anticancer Res, 32, pp.4061~4065 (2012)
- Creasman WT, "Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer", Int J Gynaecol Obstet, 95(Suppl 1), pp.S105~S143 (2006)[DOI]
- Apostolou G, "Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative", benign hyperplastic endometrium by imprint cytology, 2014, pp.42, 134~142
- Daniilidou K, "Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma: a retrospective clinicopathological and immunohistochemical study", J BUON, 18, pp.195~201 (2013)
- Kounelis S, "Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature", Mod Pathol, 13, pp.379~388 (2000)[DOI]
- Abdalla N, "Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer", Prz Menopauzalny, 15, pp.133~137 (2016)
- Coenegrachts L, "Increased expression of placental growth factor in high-grade endometrial carcinoma", Oncol Rep, 29, pp.413~418 (2013)[DOI]
- Kashima H, "Laminin C1 expression by uterine carcinoma cells is associated with tumor progression", Gynecol Oncol, 139, pp.338~344 (2015)[DOI]
- Guan H, "Prognosis and reproducibility of new and existing binary grading systems for endometrial carcinoma compared to FIGO grading in hysterectomy specimens", Int J Gynecol Cancer, 21, pp.654~660 (2011)[DOI]
- Kapucuoglu N, "Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters", Int J Gynecol Cancer, 18, pp.790~796 (2008)[DOI]
- Leung C, "Expression of myoferlin in human and murine carcinoma tumors: role in membrane repair, cell proliferation, and tumorigenesis", Am J Pathol, 182, pp.1900~1909 (2013)[DOI]
- Blomme A, "Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer", Oncogene, 36, pp.2116~2130 (2017)[DOI]
- Song DH, "Myoferlin expression in non-small cell lung cancer: prognostic role and correlation with VEGFR-2 expression", Oncol Lett, 11, pp.998~1006 (2016)[DOI]
- Kumar B, "High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status", Oncotarget, 7, pp.18665~18677 (2016)
- Wang WS, "iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma", J Proteomics, 91, pp.453~465 (2013)[DOI]
- Nishimura Y, "Cytologic scoring of endometrioid adenocarcinoma of the endometrium", Cancer, 105, pp.8~12 (2005)